Hexagon Bio logo

Hexagon Bio Funding & Investors

Hexagon Bio is a data-driven biotech developing targeted small molecule therapeutics. Our proprietary platform combines data science and synthetic biology to discover and engineer drugs from DNA sequences. We are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs.

hexagonbio.com

Total Amount Raised: $193,600,000

Hexagon Bio Funding Rounds

  • Series B

    $77,300,000

    Series B Investors

    CPPIB Credit Investments
    8VC
    Nextech Invest
    Column Group
    Two Sigma Ventures
    ATEL Capital Group
  • Series Unknown

    $61,000,001

    Series Unknown Investors

    Nextech Invest
    8VC
    SoftBank Vision Fund
    Casdin Capital
    Two Sigma Ventures
    Column Group
  • Series A

    $47,000,000

    Series A Investors

    Column Group
    8VC
    Two Sigma Ventures
    LeFrak Organization
  • Seed

    $8,300,000

    Seed Investors

    8VC
    bpd partners
Funding info provided by Diffbot.